↓ Skip to main content

Dove Medical Press

Article Metrics

What is this page? Embed badge

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan

Overview of attention for article published in Vascular Health and Risk Management, October 2013
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
49 Mendeley
Summary Twitter Dimensions citations
Title
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
Published in
Vascular Health and Risk Management, October 2013
DOI 10.2147/vhrm.s50831
Pubmed ID
24124375
Authors

Nikos Maniadakis, Fotini Gialama

Abstract

Hypertension represents a major health problem, affecting more than one billion adults worldwide. Irbesartan, an angiotensin II receptor blocker, is considered to be a highly effective treatment in the management of hypertension. The purpose of this review is to evaluate the efficacy, safety and tolerability profile, and cost-effectiveness of treatment with irbesartan in hypertension.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 20%
Student > Ph. D. Student 8 16%
Researcher 7 14%
Student > Bachelor 4 8%
Professor 2 4%
Other 6 12%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 16 33%
Pharmacology, Toxicology and Pharmaceutical Science 8 16%
Economics, Econometrics and Finance 4 8%
Chemistry 2 4%
Immunology and Microbiology 1 2%
Other 3 6%
Unknown 15 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2013.
All research outputs
#15,281,593
of 22,725,280 outputs
Outputs from Vascular Health and Risk Management
#500
of 753 outputs
Outputs of similar age
#127,575
of 207,105 outputs
Outputs of similar age from Vascular Health and Risk Management
#15
of 19 outputs
Altmetric has tracked 22,725,280 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 753 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,105 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

This page is hosted by Altmetric on behalf of Dove Medical Press.